Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Synmosa Biopharma Corp (4114) Income Statement

Synmosa Biopharma Corp Income Statement

Last quarter (Q2 2026), Synmosa Biopharma Corp's total revenue was NT$1.92B, an increase of 19.20% from the same quarter last year. In Q2, Synmosa Biopharma Corp's net income was NT$238.58M. See Synmosa Biopharma Corp’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 6.19BNT$ 5.55BNT$ 5.14BNT$ 4.39BNT$ 3.23B
NT$ 2.54BNT$ 2.40BNT$ 2.12BNT$ 1.83BNT$ 1.29B
NT$ 1.90BNT$ 1.66BNT$ 1.50BNT$ 1.37BNT$ 1.10B
Depreciation and AmortizationNT$ 343.20MNT$ 341.97MNT$ 339.92MNT$ 320.38MNT$ 302.06M
NT$ 1.12BNT$ 1.06BNT$ 1.01BNT$ 1.10BNT$ 507.92M
NT$ 778.48MNT$ 739.08MNT$ 614.74MNT$ 788.00MNT$ 207.68M
NT$ 21.17MNT$ -80.01MNT$ -13.18MNT$ -62.99MNT$ -53.79M
NT$ 799.64MNT$ 659.07MNT$ 601.56MNT$ 725.01MNT$ 153.89M
NT$ 821.85MNT$ 684.68MNT$ 594.83MNT$ 799.09MNT$ 303.86M
Per Share Metrics
Basic EPSNT$ 1.66NT$ 1.47NT$ 1.46NT$ 2.25NT$ 0.84
Diluted EPSNT$ 1.66NT$ 1.61NT$ 1.46NT$ 2.24NT$ 0.83
Weighted Average Shares Outstanding372.55M422.61M407.51M355.49M361.59M
Weighted Average Shares Outstanding (Diluted)372.55M424.10M407.51M356.68M362.79M

Currency in TWD

Synmosa Biopharma Corp Earnings and Revenue History

02.5B5B7.5B0 %8 %16 %24 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin